Fundación Cardioinfantil-Instituto de Cardiología

Bogotá 111311

1 studies enrolling now · 8 studies all time

What they study most

Hypertension, MPS III B, Mucopolysaccharidosis II, Mucopolysaccharidosis Type IIIB, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, SARS-CoV Infection

Studies at this site

• A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) — Running, not enrolling
• Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLE — Enrolling by invitation
• VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study — Completed
• A Treatment Extension Study of Mucopolysaccharidosis Type IIIB — Status unconfirmed
• A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) — Status unconfirmed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• A Treatment Study of Mucopolysaccharidosis Type IIIB — Completed
• A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents — Stopped early